xtandi
astellas pharma europe b.v. - enzalutamide - Простатни неоплазми - Ендокринна терапия - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
enzalutamide sandoz 40 mg film-coated tablets
40 mg film-coated tablets
erleada
janssen-cilag international nv - apalutamide - Простатни неоплазми - Ендокринна терапия - erleada е посочено:при възрастни мъже за лечение на не metastatic кастраци-упорит рак на простатата (nmcrpc), които са с висок риск от развитие на метастатичен болест. при възрастните мъже за лечение на метастатичен хормонално чувствителен на рак на простатата (mhspc) в комбинация с терапия за лишаване от андроген (adt).
bicalutamide accord 50 mg film - coated tablets
accord healthcare limited - Бикалутамид - 50 mg film - coated tablets
bicalutamide kabi 50 mg film - coated tablets
fresenius kabi oncology plc. - 50 mg film - coated tablets
bicalutamide kabi 150 mg film - coated tablets
fresenius kabi oncology plc. - 150 mg film - coated tablets
calumid, 50 mg film-coated tablets x 30 x 90
gedeon richter plc. - Бикалутамид -
bicusan 50 mg film - coated tablets
actavis group ptc ehf. - 50 mg film - coated tablets
bicusan 150 mg film - coated tablets
actavis group ptc ehf. - 150 mg film - coated tablets
bicalodex 50 mg film - coated tablets
Чайкафарма Висококачествените лекарства АД - Бикалутамид - 50 mg film - coated tablets